Dr. Srikanth Reddy Maddika, MD

Dr. Maddika practices at Wellstar Spalding Medical Center - Mammography in Griffin, Georgia.

Dr. Maddika's NPI, 1033528690, was assigned on August 7, 2014. Dr. Maddika holds Georgia license 89947.

Dr. Maddika's primary practice is Wellstar Spalding Medical Center - Mammography, at 601 South 8th St., Griffin, GA 30224. The practice phone is (470) 935-4483.

Dr. Maddika's primary practice is Wellstar Spalding Medical Center - Mammography in Griffin, Georgia. Dr. Maddika is also affiliated with Wellstar Spalding Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Maddika to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maddika practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Maddika's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Maddika's licenses on file in 3 states: Georgia, Illinois and New York.

CMS data shows 1,237 Medicare services from Dr. Maddika across 5 procedure codes in 2024, for 454 Medicare patients. Medicare paid $101,164 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 454 Medicare patients who saw Dr. Maddika in 2024. The largest group is 75 to 84, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maddika's median patient age at 73, with 54% women.

In 2024, Dr. Maddika wrote 639 Medicare Part D claims for 261 patients. 83% of them were for generic drugs. CMS names the drug for 362 of them, across 16 drugs with 11 or more claims each, at $36,049 in total drug cost. In 2023, CMS named 120 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Maddika for performance year 2024, reported through an alternative payment model (APM). Dr. Maddika accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Dr. Maddika from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $522.